Targazyme
Executive Chairman and Founder
Cisco 1999 - 2003
Program Leader - Voice Over Internet New Business Venture
Qualcomm 1997 - 1999
Head of Product Management
At&T 1986 - 1997
Strategic Business Unit Management, General Manager of New Business Ventures
M&M Mars Procter & Gamble 1984 - 1986
Brand Management Internship
Education:
Massachusetts Institute of Technology 1986 - 1988
Master of Business Administration, Masters
Boston University 1982 - 1984
Bachelor of Applied Science, Bachelors, Marketing, Finance
Marymount Convent Secondary School
Skills:
Medical Devices Start Ups Biotechnology Lifesciences Product Development Strategy Patents Commercialization Clinical Development Clinical Trials New Business Development Technology Transfer Venture Capital Cancer Mergers and Acquisitions Biopharmaceuticals Licensing Fda Drug Development Pharmaceutical Industry Drug Discovery Corporate Development Product Management R&D Strategic Alliances Oncology Cro Regulatory Affairs Clinical Research Market Development Life Sciences Business Development
Interests:
Car Racing Sweepstakes Home Improvement Art Psychology History Geology Sports See 5 Home Decoration Blues Electronics Outdoors Architecture Design Creating Dancing Music Invention Classical Somewhat of A Francophile Physical Training Rock Ballet Travel Boating Investing Anthropology Archaeology See Less Jazz Sports Cars Adventure and Exploration
Languages:
English
Us Patents
Augmentation Of Cell Therapy Efficacy Including Treatment With Alpha 1-3 Fucosyltransferase
Disclosed are methods, compositions of matter, and kits useful for augmentation of homing and engraftment of stem, progenitor and mature cells through modification of cellular membrane properties following ex vivo treatment. The methods, compositions, and cells may be used for the treatment of a wide variety of disorders in which augmentation of cell trafficking, homing and engraftment is desired.
Augmentation Of Cell Therapy Efficacy Including Treatment With Alpha 1,3 Fucosyltransferase
Disclosed are methods, compositions of matter, and kits useful for augmentation of cells through modification of cellular membrane properties following ex vivo treatment.
Augmentation Of Cell Therapy Efficacy Including Treatment With Alpha 1,3 Fucosyltransferase
- Carlsbad CA, US Leonard Miller - Carlsbad CA, US Lynnet Koh - Carlsbad CA, US
International Classification:
C12N 5/0783 A61K 35/17 C12N 5/00
Abstract:
Disclosed are methods, compositions of matter, and kits useful for augmentation of cells through modification of cellular membrane properties following ex vivo treatment.
Augmentation Of Cell Therapy Efficacy Including Treatment With Alpha 1-3 Fucoslytransferase
- Carlsbad CA, US Leonard Miller - Carlsbad CA, US Lynnet Koh - Carlsbad CA, US
Assignee:
Targazyme, Inc. - Carlsbad CA
International Classification:
C12N 5/0783 A61K 35/14
US Classification:
424 9371, 435375
Abstract:
Disclosed are methods, compositions of matter, and kits useful for augmentation of cells through modification of cellular membrane properties following ex vivo treatment.
Targazyme founder Lynnet Koh said her company is moving forward but that she left Texas because Perry's office withheld additional funding, a complaint echoed by other recipients. She now lives in California and said many of the jobs created by the company were short-term hires outside Texas, none o